OraSure Technologies Inc
NASDAQ:OSUR
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.75
8.35
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
OraSure Technologies Inc
Total Liabilities
OraSure Technologies Inc
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
OraSure Technologies Inc
NASDAQ:OSUR
|
Total Liabilities
$38.5m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
||
Haemonetics Corp
NYSE:HAE
|
Total Liabilities
$1.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
22%
|
CAGR 10-Years
10%
|
||
ICU Medical Inc
NASDAQ:ICUI
|
Total Liabilities
$2.3B
|
CAGR 3-Years
108%
|
CAGR 5-Years
50%
|
CAGR 10-Years
51%
|
||
Align Technology Inc
NASDAQ:ALGN
|
Total Liabilities
$2.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
27%
|
||
Lantheus Holdings Inc
NASDAQ:LNTH
|
Total Liabilities
$869.9m
|
CAGR 3-Years
36%
|
CAGR 5-Years
24%
|
CAGR 10-Years
6%
|
||
Merit Medical Systems Inc
NASDAQ:MMSI
|
Total Liabilities
$1.1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
OraSure Technologies Inc
Glance View
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 785 full-time employees. The firm's products include molecular sampling kits for the genome and microbiome services and analytics, rapid diagnostics for infectious disease, and tests for substance abuse. OraSure’s segments include Diagnostics segment and Molecular Collection Systems segment. The Diagnostics business primarily consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. The Molecular Solutions business consists of the manufacture and sale of kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbiome and animal genetics markets.
See Also
What is OraSure Technologies Inc's Total Liabilities?
Total Liabilities
38.5m
USD
Based on the financial report for Sep 30, 2024, OraSure Technologies Inc's Total Liabilities amounts to 38.5m USD.
What is OraSure Technologies Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
3%
Over the last year, the Total Liabilities growth was -28%. The average annual Total Liabilities growth rates for OraSure Technologies Inc have been -17% over the past three years , and 3% over the past ten years .